Sumitomo Mitsui Trust Group
TEVA icon

Sumitomo Mitsui Trust Group’s Teva Pharmaceuticals TEVA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3M Buy
2,340,457
+166,618
+8% +$5.55M 0.05% 346
2026
Q1 		$65.5M Buy
2,173,839
+186,447
+9% +$6M 0.04% 365
2025
Q4 		$62M Sell
1,987,392
-469,305
-19% -$11.6M 0.04% 405
2025
Q3 		$49.6M Buy
2,456,697
+1,381
+0.1% +$24.3K 0.03% 475
2025
Q2 		$41.2M Sell
2,455,316
-48,691
-2% -$786K 0.03% 512
2025
Q1 		$38.5M Buy
2,504,007
+134,705
+6% +$2.41M 0.03% 511
2024
Q4 		$52.2M Buy
2,369,302
+405,741
+21% +$7.38M 0.04% 434
2024
Q3 		$35.4M Sell
1,963,561
-10,545
-0.5% -$185K 0.02% 548
2024
Q2 		$32.1M Sell
1,974,106
-185,227
-9% -$2.85M 0.02% 543
2024
Q1 		$30.5M Buy
2,159,333
+27,713
+1% +$349K 0.02% 627
2023
Q4 		$22.3M Sell
2,131,620
-12,756
-0.6% -$119K 0.02% 684
2023
Q3 		$21.9M Sell
2,144,376
-13,101
-0.6% -$122K 0.02% 677
2023
Q2 		$16.2M Sell
2,157,477
-478,893
-18% -$3.88M 0.01% 738
2023
Q1 		$23.3M Sell
2,636,370
-10,002
-0.4% -$98.9K 0.02% 696
2022
Q4 		$24.1M Sell
2,646,372
-30,252
-1% -$264K 0.02% 677
2022
Q3 		$21.6M Sell
2,676,624
-15,536
-0.6% -$137K 0.02% 690
2022
Q2 		$20.2M Buy
2,692,160
+148,351
+6% +$1.29M 0.02% 717
2022
Q1 		$23.9M Buy
2,543,809
+15,803
+0.6% +$132K 0.02% 703
2021
Q4 		$20.2M Sell
2,528,006
-198,537
-7% -$1.79M 0.01% 712
2021
Q3 		$26.6M Sell
2,726,543
-64,943
-2% -$608K 0.02% 673
2021
Q2 		$27.6M Sell
2,791,486
-141,480
-5% -$1.5M 0.02% 682
2021
Q1 		$33.8M Sell
2,932,966
-190,557
-6% -$2.19M 0.02% 631
2020
Q4 		$30.1M Sell
3,123,523
-529,566
-14% -$5.07M 0.02% 650
2020
Q3 		$32.9M Sell
3,653,089
-480,944
-12% -$5.09M 0.02% 597
2020
Q2 		$51M Sell
4,134,033
-68,540
-2% -$775K 0.04% 488
2020
Q1 		$37.7M Buy
4,202,573
+155,728
+4% +$1.6M 0.03% 517
2019
Q4 		$39.7M Buy
4,046,845
+60,552
+2% +$541K 0.03% 548
2019
Q3 		$27.4M Sell
3,986,293
-18,781
-0.5% -$144K 0.02% 599
2019
Q2 		$37M Buy
4,005,074
+458,751
+13% +$5.53M 0.03% 528
2019
Q1 		$55.6M Sell
3,546,323
-40,494
-1% -$714K 0.05% 384
2018
Q4 		$56.3M Buy
3,586,817
+575,709
+19% +$11.8M 0.06% 329
2018
Q3 		$64.9M Buy
3,011,108
+19,766
+0.7% +$459K 0.07% 308
2018
Q2 		$72.7M Buy
2,991,342
+288,406
+11% +$5.88M 0.08% 260
2018
Q1 		$46.2M Buy
2,702,936
+5,870
+0.2% +$115K 0.06% 351
2017
Q4 		$51.1M Buy
2,697,066
+52,144
+2% +$784K 0.07% 315
2017
Q3 		$46.6M Sell
2,644,922
-35,640
-1% -$802K 0.07% 312
2017
Q2 		$89M Buy
2,680,562
+23,246
+0.9% +$720K 0.13% 185
2017
Q1 		$85.3M Sell
2,657,316
-10,917
-0.4% -$373K 0.13% 183
2016
Q4 		$96.7M Buy
+2,668,233
New +$107M 0.16% 149

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TEVA Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Teva Pharmaceuticals (TEVA) stake by 7.7% in Q2 2026, buying an estimated $5.55M and bringing the position to 2,340,457 shares worth $79.3M. The position accounts for 0.05% of the portfolio, ranked #346.

Sumitomo Mitsui Trust Group first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. The position peaked at $96.7M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 2,340,457 shares of Teva Pharmaceuticals worth $79.3M as of Q2 2026.
  • Sumitomo Mitsui Trust Group bought 166,618 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.55M.
  • Teva Pharmaceuticals made up 0.05% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #346 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Sumitomo Mitsui Trust Group's Teva Pharmaceuticals position peaked at $96.7M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.